Chromatin remodeler Znhit1 preserves hematopoietic stem cell quiescence by determining the accessibility of distal enhancers

Leukemia
Shenfei SunBing Zhao

Abstract

Hematopoietic stem cell (HSC) utilizes its quiescence feature to combat exhaustion for lifetime blood cell supply. To date, how certain chromatin architecture and subsequent transcription profile permit HSC quiescence remains unclear. Here, we show an essential role of chromatin remodeler zinc finger HIT-type containing 1 (Znhit1) in maintaining HSC quiescence. We find that loss of Znhit1 leads to exhaustion of stem cell pool and impairment of hematopoietic function. Mechanically, Znhit1 determines the chromatin accessibility at distal enhancers of HSC quiescence genes, including Pten, Fstl1, and Klf4, for sustained transcription and consequent PI3K-Akt signaling inhibition. Moreover, Znhit1-Pten-PI3K-Akt axis also participates in controlling myeloid expansion and B-lymphoid specification. Our findings therefore identify a dominant role of Znhit1-mediated chromatin remodeling in preserving HSC function for hematopoietic homeostasis.

References

Mar 10, 2000·Science·T ChengD T Scadden
Jun 19, 2002·Blood·Scott C KoganUNKNOWN Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium
Feb 26, 2008·Cell·Stuart H Orkin, Leonard I Zon
Nov 22, 2008·Cold Spring Harbor Symposia on Quantitative Biology·M P ChaoI L Weissman
Sep 29, 2009·Molecular Cell·Gordon L HagerTom Misteli
Dec 17, 2009·BMC Biology·Deanna DryhurstJuan Ausió
Oct 5, 2010·Cell Stem Cell·Song ChouHarvey Lodish
Feb 4, 2011·Experimental Hematology·June Li
Sep 3, 2011·Cell Stem Cell·Akinobu MatsumotoKeiichi I Nakayama
Feb 7, 2012·Cell Stem Cell·Sergei DoulatovJohn E Dick
Jun 20, 2012·Proceedings of the National Academy of Sciences of the United States of America·Alexander L KovalchukRafael Casellas
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
May 24, 2013·Nature Reviews. Molecular Cell Biology·Tom H Cheung, Thomas A Rando
May 30, 2013·Development·Peter J Skene, Steven Henikoff
Jan 22, 2014·The Journal of Experimental Medicine·Joseph Y ShinChristopher Y Park
Mar 13, 2014·Nature Reviews. Genetics·Daria ShlyuevaAlexander Stark
Apr 4, 2014·Genes & Development·Christopher M Weber, Steven Henikoff
Dec 4, 2014·Development·Ayako Nakamura-IshizuToshio Suda
Feb 24, 2015·F1000prime Reports·Vidya SubramanianLaurie A Boyer
Aug 19, 2015·Frontiers in Oncology·Miriam Bermúdez BritoEvangelia A Papakonstanti
Feb 18, 2016·The Journal of Experimental Medicine·Per HolmfeldtShannon McKinney-Freeman
Jan 13, 2017·Experimental Hematology & Oncology·Natalia-Del Pilar Vanegas, Jean-Paul Vernot
Nov 26, 2018·Cell Stem Cell·Sun-Mi ParkMichael G Kharas
Jan 25, 2019·Nature Reviews. Genetics·Sandy L KlemmWilliam J Greenleaf

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
RNA-seq
ChIP-seq

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.